TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5856$ +1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow HUMA
Line item 2019 2020 2021 2022 2023 2024 2025
-1,160.3% -3,726.9% -6,428.3% -4,545.0% -5,154.2%
109.1% 565.5% 652.5% 524.6% 261.4%
72.0% 314.8% 803.3% 395.1% 478.6%
74.2% 333.6% -3,877.0% -4,472.5%
7.3% -158.9% -44.1% 65.8% -1,147.9%
131.3% 21.3% 17.4% 67.0% 43.4%
-131.3% -18.0% -650.8% 309.6% -43.4%
0.0%
19,239.7% 34.2%
-20.9% 117.4% 2,348.3% -126.6% 1,816.9%
-1.2% 137.6% 21,138.8% -92.4% 3,017.0%
-1,292.8% 2,678.0% 14,059.6% -4,327.8% -2,180.6%
-1,291.6% -3,748.2% -6,445.8% -4,611.9% -5,197.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?